Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Katherine L. Pratt"'
Autor:
Peng Fang, Brian M. Little, Jaime Guevara-Aguirre, Vivian Hwa, Rose Girgis, Ron G. Rosenfeld, Katherine L. Pratt
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 93:1030-1037
Context: Among more than 250 cases of GH insensitivity syndrome (GHIS) reported to date, the largest cohort was identified in southern Ecuador. In the Ecuadorian GHIS cohort, a sense mutation (GAA > GAG) at codon E180 of GH receptor [GHR (E180sp)] re
Autor:
Vivian Hwa, Peng Fang, Herwig Frisch, Brian M. Little, Serge Amselem, Ron G. Rosenfeld, Gabriele Haeusler, Stefan Riedl, Katherine L. Pratt
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:2223-2231
Primary GH insensitivity (GHI) or Laron syndrome, caused by mutations of the GH receptor (GHR) gene, has a clinical phenotype of postnatal growth failure associated with normal elevated serum concentrations of GH and low serum levels of IGF-I.We inve
Autor:
Ron G. Rosenfeld, José Manuel Fernández-Real, Abel López-Bermejo, Wifredo Ricart, Maria García-Gil, Javad Khosravi, Roser Casamitjana, Katherine L. Pratt, Vivian Hwa
Publikováno v:
Diabetes. 55:2333-2339
IGF-binding protein (IGFBP)-related protein 1 (IGFBP-rP1) has been shown to bind both IGFs and insulin, albeit with low affinity, and to inhibit insulin signaling. We hypothesized that IGFBP-rP1 is associated with insulin resistance and components of
Autor:
Pelin Adiyaman, Brian M. Little, Eric M. Kofoed, Merih Berberoğlu, Vivian Hwa, Gönül Öcal, Ron G. Rosenfeld, Katherine L. Pratt
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:4260-4266
Context: The central clinical feature of GH insensitivity (GHI) is severe growth failure associated with elevated serum concentrations of GH and abnormally low serum levels of IGF-I. GHI can be the result of an abnormality in the GH receptor or aberr
Autor:
Katherine L. Pratt, Stephen H. LaFranchi, Jonathan Q. Purnell, Andrea M. Haqq, Ron G. Rosenfeld, David E. Cummings, Diane D. Stadler, David S. Weigle, R. Scott Frayo
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:3573-3576
Prader-Willi syndrome (PWS) is characterized by severe obesity, hyperphagia, hypogonadism, and GH deficiency. Unlike individuals with common obesity, who have low fasting-plasma ghrelin concentrations, those with PWS have high fasting-ghrelin concent
Autor:
Stephen H. LaFranchi, Andrea M. Haqq, Ron G. Rosenfeld, Diane D. Stadler, Jonathan Q. Purnell, I. Sadaf Farooqi, Katherine L. Pratt, Stephen O'Rahilly
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:174-178
Ghrelin, an endogenous ligand of the GH secretagogue receptor, stimulates appetite and causes obesity in animal models and in humans when given in pharmacologic doses. Prader-Willi Syndrome (PWS) is a genetic obesity syndrome characterized by GH defi
Autor:
Ron G. Rosenfeld, Annamaria Colao, Carolina Di Somma, Gaetano Lombardi, Anastasia Diamandis, Katherine L. Pratt, Javad Khosravi, Paolo Marzullo
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:3001-3008
The diagnostic approach to acromegaly and GH deficiency frequently includes measurement of several components of the insulinlike growth factor (IGF) system. IGF-I levels are reported to be good predictors of active and cured acromegaly, but are commo
Autor:
Wei Wu, David W. Rose, Anatoli S. Gleiberman, Forrest Liu, Christopher K. Glass, Anna Krones, Ron G. Rosenfeld, Daniel P. Szeto, Michael G. Rosenfeld, Ola Hermanson, Katherine L. Pratt, Zhiyong Wang, Thomas Herman
Publikováno v:
Proceedings of the National Academy of Sciences. 97:13549-13554
A family of p160 coactivators was initially identified based on ligand-dependent interactions with nuclear receptors and thought to function, in part, by recruiting CREB-binding protein/p300 to several classes of transcription factors. One of the p16
Autor:
Brian M. Little, Katherine L. Pratt, Ron G. Rosenfeld, Daisy Chin, Vivian Hwa, Anna M. Aalbers, Stuart J. Frank
Publikováno v:
Hormone research. 71(5)
Background/Aims: Circulating growth hormone-binding protein (GHBP), in humans, is the proteolytic product of the growth hormone receptor (GHR). We investigated a prepubertal male subject who was of short stature, but who had a markedly elevated serum
Autor:
Vivian Hwa, Abel López-Bermejo, Katherine L. Pratt, Ron G. Rosenfeld, Antoni Castro, José Manuel Fernández-Real, Wifredo Ricart, Roser Casamitjana, Javad Khosravi
Publikováno v:
Diabetes care. 30(6)
Type 2 diabetes is characterized by variable degrees of vascular dysfunction (1,2). We have recently reported improved vasomotor responses in high-ferritin type 2 diabetic patients following bloodletting (3), an intervention that is believed to reduc